Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Break! Middle East.
Press releases published on August 5, 2025
Rhythm Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Update
GlobeNewswire
·
August 5, 2025
-- Second quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $48.5 million -- -- U.S. and EU regulatory submissions for setmelanotide in acquired hypothalamic obesity on track to be completed in the third quarter of 2025 -- …
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 5, 2025
SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and financial results for its second quarter ended June 30, …
Amneal Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 5, 2025
‒ Q2 2025 Net Revenue of $725 million; GAAP Net Income of $22 million; Diluted Income per Share of $0.07 ‒ ‒ Adjusted EBITDA of $184 million; Adjusted Diluted EPS of $0.25 ‒ ‒ Raising 2025 Full Year Guidance ‒ ‒ Full Debt Refinancing Reduces Interest Cost …
Aicuris Presents Pharmacokinetic Data from the First-in-Human Clinical Trial of AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus, at World Transplant Congress
GlobeNewswire
·
August 5, 2025
Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2nd generation antisense oligonucleotide (ASO), in healthy volunteers demonstrated favorable pharmacokinetic (PK) characteristics AIC468 was safe and well tolerated in all …
Fortuna Advances Diamba Sud Gold Project in Senegal with Updated Mineral Resources; PEA Completion Targeted for Q4 2025
GlobeNewswire
·
August 5, 2025
VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is pleased to report an updated Mineral Resource estimate as of July 7, 2025, for the Diamba Sud Gold Project located in Senegal. All dollar amounts …
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
GlobeNewswire
·
August 5, 2025
BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …